Relation Between Serum IGF-1 & BMI In Acne Vulgaris

Relation Between Serum Insulin Like Growth Factor 1 and Body Mass Index in Acne Vulgaris

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05301569

Enrollment

Registered

2022-03-29

Start date

2023-04-01

Completion date

2024-05-30

Last updated

2023-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of Serum Level of Insulin Like Growth Factor 1

Brief summary

cross-sectional study in which participants will be recruited at dermatology & Andrology out-patient clinics in Assuit university hospital, Egypt after patients examination by dermatologists & obtaining an informed consent

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

15 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

1. Patients aged from 15 to 45 years old suffering from acne vulgaris. 2. Both sexes.

Exclusion criteria

1. Insulin resistance and diabetic patients 2. Females with polycystic ovarian syndrome 3. Treatment with drugs that can influence IGF-1level such as corticosteroid, insulin, hypoglycemic agents, and isotretinoin within one year before the date of study. 4. Other causes of acne or acneform eruption as steroid-induced

Design outcomes

Primary

Measure	Time frame	Description
Evaluation of serum level of insulin like growth factor 1 in acne vulgaris	1 year	using the Chemiluminescent Microparticle Immunoassay

Countries

Egypt

Contacts

Primary ContactRania Sallam

Raniamohamed0887@gmail.com113567939

Outcome results